Characterization and mapping of regulator and payer evidence challenges in PCa

Report on the key evidence challengesgaps for regulators and payerHTA authorities in the last 23 years including an analyses of the key decision drivers of key payerHTA for access decisions and assessment of current inequalities in patient access to prostate cancer treatments across Europe